Development of biomarkers for Huntington's disease

Summary Huntington's disease is an autosomal dominant, progressive neurodegenerative disorder, for which there is no disease-modifying treatment. By use of predictive genetic testing, it is possible to identify individuals who carry the gene defect before the onset of symptoms, providing a wind...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lancet neurology 2011-06, Vol.10 (6), p.573-590
Hauptverfasser:	Weir, David W, BSc, Sturrock, Aaron, MBBS, Leavitt, Blair R, MDCM
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer's disease Antioxidants - metabolism Biomarkers Biomarkers - metabolism Brain - anatomy & histology Brain - metabolism Brain - pathology Brain - physiopathology Clinical trials Diagnostic Imaging - methods Disease Progression Endocrine System - physiology Genotype & phenotype Humans Huntington Disease - diagnosis Huntington Disease - genetics Huntington Disease - pathology Huntington Disease - physiopathology Huntingtons disease Magnetic Resonance Imaging Medical imaging Mutation Neurobiology Neuroimaging Neurology Observational studies Oxidative Stress
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!